U.S. And Europe Cleanrooms Market Size to hit Around USD 9.12 Billion by 2033

The U.S. and Europe cleanrooms market size was exhibited at USD 6.85 billion in 2023 and is projected to hit around USD 9.12 billion by 2033, growing at a CAGR of 2.9% during the forecast period 2024 to 2033.

Download Free Sample Copy for Better Understanding@ https://www.novaoneadvisor.com/report/sample/8372

U.S. And Europe Cleanrooms Market Key Takeaways:

• The compounding pharmacies segment accounted for the largest revenue share of 92.9% in 2023 and is expected to grow at the fastest CAGR of 2.8% during the forecast period.
• The hospital segment held a considerable market share in 2023.
• The U.S. dominated the market and accounted for the largest revenue share of 59.8% in 2023 and it is also expected to grow at the fastest CAGR of 2.7% during the forecast period.
• Europe is expected to witness a lucrative CAGR over the forecast period.

Growing government regulations for sterile & hazardous drug compounding, especially in the U.S., and increasing incidence of Hospital-acquired Infections (HAIs) are some of the key factors boosting demand for cleanrooms in hospitals & compounding pharmacies. Moreover, technological advancements are also positively impacting the market growth over the forecast period.

In the U.S., market penetration in compounding pharmacies is high due to regulations such as USP 797 and USP 800. According to the Pharmacy Purchasing and Products report published in 2023, compounding sites reported 75% compliance with USP 797 standards, and about 47% of compounding sites were compliant with the newly proposed USP 800 standards. Thus, stringent regulations for drug compounding contribute to market growth.

The growing incidence of hospital-acquired infections (HAIs) is one of the major factors boosting demand from hospitals. According to a report by the Centers for Disease Control and Prevention (CDC), there were nearly 722,000 HAIs in the U.S. Similarly, according to the data published by the National Institute for Health and Care Excellence, in England, about 300,000 patients contract HAIs every year due to care within the National Health Service.

Modular cleanrooms are replacing conventional cleanrooms owing to their advanced features, such as low cost of installation, ease of mobility, and flexibility. They provide intrinsic versatility, as they can be assembled, disassembled, and relocated. In September 2023, Guardtech Cleanrooms Ltd expanded its CleanCube Mobile Cleanrooms range by launching three new models CleanCube Equip, CleanCube Bio, and CleanCube Pharma.

There are several benefits associated with modular cleanrooms, which include fast installations and reconfiguration based on requirements. Furthermore, modular cleanrooms in pharmaceutical compounding provide flexibility and cost-effectiveness while enabling compliance with regulation and maintaining contamination control for high-quality medications.

Many prominent companies are engaging in developing modular cleanrooms. For instance, North Central Instruments (NCI) offers a range of these in softwall and hardwall configurations. Their adoption is high in compounding pharmacies as compared to hospitals.

U.S. And Europe Cleanrooms Market By End-use Insights

The compounding pharmacies segment accounted for the largest revenue share of 92.9% in 2023 and is expected to grow at the fastest CAGR of 2.8% during the forecast period. Pharmacies involved in compounding sterile and hazardous drugs are required to meet certain cleanliness standards. The abovementioned factors have led to increased penetration in compounding units. Growing demand is driving prominent players to develop cleanrooms for compounding pharmacies. For instance, Terra Universal, Inc. offers FDA-accredited cleanrooms under its All-Steel Pharmaceutical Cleanrooms range. The product line includes USP 797 BioSafe and USP 800 BioSafe All-Steel Cleanrooms, along with USP 797 and USP 800 Hardwall Cleanrooms.

The hospital segment held a considerable market share in 2023. Hospital laboratories process biological samples such as urine, serum, plasma, & tissue. It is essential to keep these instruments contamination-free for executing accurate processing of a sample. In such laboratories, the presence of a clean environment is crucial. Factors such as growing cases of HIAs and increasing adoption in oncology, burn & operating units, and gene therapy departments within the hospital facilities contribute toward segment growth.

U.S. And Europe Cleanrooms Market By Regional Insights

The U.S. dominated the market and accounted for the largest revenue share of 59.8% in 2023 and it is also expected to grow at the fastest CAGR of 2.7% during the forecast period. Well-established healthcare infrastructure and a large number of cleanroom providers in the country contribute toward increased market share. In addition, the growing number of hospital admissions also propels the market. It is estimated that around 34 million hospital admissions were reported in 2023. Moreover, the increasing prevalence of HIAs also boosts demand. According to the CDC, HIAs account for almost 1.7 million infections each year in the U.S.

Europe is expected to witness a lucrative CAGR over the forecast period. Europe’s cleanroom market is majorly fueled by high healthcare expenditure and the presence of well-developed healthcare infrastructure, especially in Western Europe. Favorable government initiatives toward infection control and healthcare infrastructure improvements are among the few factors responsible for the increase in demand for cleanrooms. In addition, the rising prevalence of nosocomial infections is one of the major factors boosting demand among hospitals in the region. According to a report by World Health Organization (WHO), 8.9 million healthcare-acquired infections occur annually in the European Region.?

Some of the prominent players in the U.S. and Europe cleanrooms market include:

• ISOLTECH Srl
• ALLIED CLEANROOMS
• Angstrom Technology
• Nicomac Srl
• Terra Universal, Inc.
• MECART
• Clean Room Depot
• Clean Air Products
• Asgatech Holding Ltd.

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the U.S. and Europe cleanrooms market

End-use

• Compounding Pharmacies
• Hospitals

Regional

• U.S.
• Europe

Quick Buy This Premium Report From Here: https://www.novaoneadvisor.com/report/checkout/8372 ?

Access our Premium Real Time Data Intelligence Tool, Visit: www.precedencestatistics.com

You can place an order or ask any questions, please feel free to [email protected]| +1 9197 992 333

About US

Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Connect with Us

Address: Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

IND Address: 2nd Floor,Shreeleela Plaza, Baner Road, Pune, Maharashtra - 411045

Call: USA - + 1 804 441 9344| IND - + 91 87933 22019 | Europe: +44 2080772818

[email protected]

Web: https://www.novaoneadvisor.com/

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to com

Nova One Advisor Group Offer Other Reports:

Cell Therapy Market Size and Forecast:?The global?cell therapy market size was exhibited at USD 4.85 billion in 2023 and is projected to hit around USD 37.42 billion by 2033, growing at a CAGR of 22.67% during the forecast period 2024 to 2033.

Gene Therapy Market Size and Forecast?:?The global?gene therapy market size was exhibited at USD 8.75 billion in 2023 and is projected to hit around USD 52.40 billion by 2033, growing at a CAGR of 19.6% during the forecast period 2024 to 2033.

Cell And Gene Therapy Manufacturing Market Size and Forecast:?The global?cell and gene therapy manufacturing market size was estimated at USD 9.95 billion in 2023 and is projected to hit around USD 106.03 billion by 2033, growing at a CAGR of 26.7% during the forecast period from 2024 to 2033.

Cell and Gene Therapy Market?Size and Forecast:?The global?cell and gene therapy market size was estimated at USD 18.13 billion in 2023 and is projected to hit around USD 97.33 billion by 2033, growing at a CAGR of 18.3% during the forecast period from 2024 to 2033.

U.S. Cell Therapy Market Size and Forecast:?The?U.S. cell therapy market size was estimated at USD 2.88 billion in 2023 and is projected to hit around USD 19.67 billion by 2033, growing at a CAGR of 21.18% during the forecast period from 2024 to 2033.

U.S. Gene Therapy Market Size and Forecast:?The?U.S. gene therapy market size?was estimated at USD 3.19 billion in 2023 and is projected to hit around USD 18.50 billion by 2033, growing at a CAGR of 19.22% during the forecast period from 2024 to 2033.

T-cell Therapy Market Size and Forecast:?The global?T-Cell therapy market size?was exhibited at USD 3.85 billion in 2023 and is projected to hit around USD 79.62 billion by 2033, growing at a CAGR of 35.38% during the forecast period 2024 to 2033.

Cancer Immunotherapy Market?Size and Forecast:?The global?cancer immunotherapy market?size was valued at USD 126.19 billion in 2023 and is projected to surpass around USD 296.01 billion by 2033, registering a CAGR of 8.9% over the forecast period of 2024 to 2033.

Immunotherapy Drugs Market?:?The global?immunotherapy drugs market size was valued at USD 240.19 billion in 2023 and is projected to surpass around USD 1,300.38 billion by 2033, registering a CAGR of 18.4% over the forecast period of 2024 to 2033.

Clinical Trials Market Size and Forecast:?The?global clinical trials market size was estimated at USD 81.90 billion in 2023 and is projected to hit around USD 153.59 billion by 2033, growing at a CAGR of 6.49% during the forecast period from 2024 to 2033.

Biologics Market Size and Forecast: The?global biologics market size was estimated at USD 511.04 billion in 2023 and is projected to hit around USD 1,374.51 billion by 2033, growing at a CAGR of 10.4% during the forecast period from 2024 to 2033.

Biotechnology Market Size and Forecast:? The?global biotechnology market size was estimated at USD 1.54 Trillion in 2023 and is projected to hit around USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% during the forecast period from 2024 to 2033.

Oncology? Market Size and Forecast: The?global oncology market size was estimated at USD 222.36 billion in 2023 and is projected to hit around USD 521.60 billion by 2033, growing at a CAGR of 8.9% during the forecast period from 2024 to 2033.

Cell And Gene Therapy Clinical Trials?Market Size and Forecast: The global cell and gene therapy clinical trials market size reached USD 11.62 billion in 2023 and is projected to hit around USD 47.40 billion by 2033, expanding at a CAGR of 15.09% during the forecast period from 2024 to 2033.

U.S. Clinical Trials Market Size and Forecast:?The?U.S. clinical trials market size was valued at USD 25.81 billion in 2023 and is projected to surpass around USD 41.57 billion by 2033, registering a CAGR of 4.88% over the forecast period of 2024 to 2033.

Active Pharmaceutical Ingredient CDMO Market:?The global active pharmaceutical ingredient CDMO market size was valued at USD 119.80 billion in 2023 and is anticipated to reach around USD 249.22 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.

U.S. Pharmaceutical Market?:?The U.S. pharmaceutical market size was valued at USD 602.19 billion in 2023 and is projected to surpass around USD 1,093.79 billion by 2033, registering a CAGR of 6.15% over the forecast period of 2024 to 2033.

Viral Vector And Plasmid DNA Manufacturing Market:?The global viral vector and plasmid DNA manufacturing market size?was valued at USD 6.19 billion in 2023 and is anticipated to reach around USD 39.30 billion by 2033, growing at a CAGR of 20.3% from 2024 to 2033.

U.S. Viral Vector And Plasmid DNA Manufacturing Market ;?The U.S. viral vector and plasmid DNA manufacturing market size was valued at USD 2.45 billion in 2023 and is expected to be worth around USD 15.30 billion by 2033, with a registered CAGR of 20.1% during forecast period 2024 to 2033.

Compounding Pharmacies Market :?The global compounding pharmacies market size?was valued at USD 16.19 billion in 2023 and is anticipated to reach around USD 30.97 billion by 2033, growing at a CAGR of 6.7% from 2024 to 2033.

U.S. Compounding Pharmacies Market?:?The U.S. compounding pharmacies market size?is projected to be worth around USD 10.76 billion by 2033 from USD 6.31 billion in 2024, at a CAGR of 6.1% from 2024 to 2033.

Antibiotics Market: The?global antibiotics market size?was valued at USD 51.19 billion in 2023 and is projected to surpass around USD 85.80 billion by 2033, registering a CAGR of 5.3% over the forecast period of 2024 to 2033.

Biologics Market :?The?global biologics market size was estimated at USD 511.04 billion in 2023 and is projected to hit around USD 1,374.51 billion by 2033, growing at a CAGR of 10.4% during the forecast period from 2024 to 2033.

Biotechnology Market:?The?global biotechnology market size was estimated at USD 1.54 Trillion in 2023 and is projected to hit around USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% during the forecast period from 2024 to 2033.

Next Generation Sequencing Market?:?The?global next generation sequencing market size was estimated at USD 9.19 billion in 2023 and is projected to hit around USD 66.04 billion by 2033, growing at a CAGR of 21.8% during the forecast period from 2024 to 2033.

Genome Editing Market ;?The?global genome editing market size?was valued at USD 8.45 billion in 2023 and is anticipated to reach around USD 40.48 billion by 2033, growing at a CAGR of 16.96% from 2024 to 2033.

U.S. Genome Editing Market:?The?U.S. genome editing market size was estimated at USD 3.55 billion in 2023 and is projected to hit around USD 16.49 billion by 2033, growing at a CAGR of 16.6% during the forecast period from 2024 to 2033.

U.S. Gene Synthesis Market?:?The?U.S. Gene Synthesis market size was valued at USD 700.90 million in 2023 and is projected to surpass around USD 3,118.73 million by 2033, registering a CAGR of 16.1% over the forecast period of 2024 to 2033.

Biopharmaceutical Market :?The global?Biopharmaceutical market size accounted for USD 327.46 billion in 2022 and is estimated to achieve a market size of USD 1,101.77 billion by 2032 growing at a CAGR of 12.9% from 2023 to 2032.

Immunotherapy Drugs Market?:?The?global immunotherapy drugs market size was valued at USD 240.19 billion in 2023 and is projected to surpass around USD 1,300.38 billion by 2033, registering a CAGR of 18.4% over the forecast period of 2024 to 2033.

Cancer Immunotherapy Market:?The global cancer immunotherapy market size was valued at USD 126.19 billion in 2023 and is projected to surpass around USD 296.01 billion by 2033, registering a CAGR of 8.9% over the forecast period of 2024 to 2033.

U.S. Plasmid DNA Manufacturing Market?:?The U.S. plasmid DNA manufacturing market size?was valued at USD 711.90 million in 2023 and is projected to surpass around USD 4,885.15 million by 2033, registering a CAGR of 21.24% over the forecast period of 2024 to 2033.

U.S. Precision Medicine Market?:?The?U.S. precision medicine market size was valued at USD 24.95 billion in 2023 and is projected to reach around USD 76.12 billion by 2033, registering a CAGR of 11.80% from 2024 to 2033.